Institute for Safe Medication Practices

Last updated
Institute for Safe Medication Practices
Company type 501(c)(3) nonprofit organization
Founded1975  OOjs UI icon edit-ltr-progressive.svg
FounderMichael R. Cohen
Headquarters
United States  OOjs UI icon edit-ltr-progressive.svg
Website www.ismp.org   OOjs UI icon edit-ltr-progressive.svg

The Institute for Safe Medication Practices (ISMP) is an American 501(c)(3) organization focusing on the prevention of medication errors and promoting safe medication practices. [1] It is affiliated with ECRI. [2]

Activities

Among others, ISMP maintains and disseminates a list of "do not crush" medications, [3] as well as clinical best practices. [4] The ISMP's Medication Safety Self-Assessment tool has been used in surveys of medication safety in hospitals in the United States and elsewhere. [5] [6] [7] [8]

The ISMP frequently investigates and reports on medication errors that have occurred in practice. These investigations are often published in the peer-reviewed journal Hospital Pharmacy. [9] [10] [11]

References

  1. ↑ Guidestar. "Institute for Safe Medication Practices". Guidestar by Candid. Retrieved 2021-06-30.
  2. ↑ ECRI. "ECRI and the Institute for Safe Medication Practices (ISMP) Launch New Patient Safety Organization". www.prnewswire.com (Press release). Retrieved 2021-06-30.
  3. ↑ Cohen, Michael R. (July 2007). ""Do Not Crush" list" . Nursing2021. 37 (7): 12. doi:10.1097/01.NURSE.0000279404.54880.3a. ISSN   0360-4039.
  4. ↑ "ISMP Publishes 2020-2021 Consensus-Based Medication Safety Best Practices for Hospitals". Institute For Safe Medication Practices. 27 February 2020. Retrieved 2021-06-30.
  5. ↑ Lesar, Timothy; Mattis, Arnold; Anderson, Ernest; Avery, Jean; Fields, John; Gregoire, Jill; Vaida, Allen; VHA New England Medication Error Prevention Initiative Collaborative (2003-05-01). "Using the ISMP Medication Safety Self-Assessment™ to Improve Medication Use Processes" . The Joint Commission Journal on Quality and Safety. 29 (5): 211–226. doi:10.1016/S1549-3741(03)29026-2. ISSN   1549-3741. PMID   12751302 – via Elsevier Science Direct.
  6. ↑ Vaida, Allen J.; Lamis, Rebecca L.; Smetzer, Judy L.; Kenward, Kevin; Cohen, Michael R. (2014-02-01). "Assessing the State of Safe Medication Practices Using the ISMP Medication Safety Self Assessment® for Hospitals: 2000 and 2011" . The Joint Commission Journal on Quality and Patient Safety. 40 (2): 51–AP3. doi:10.1016/S1553-7250(14)40007-2. ISSN   1553-7250. PMID   24716328.
  7. ↑ Greenall, Julie; Shastay, Ann; Vaida, Allen J; U, David; Johnson, Philip E; O’Leary, Joe; Chambers, Carole (2015-02-01). "Establishing an international baseline for medication safety in oncology: Findings from the 2012 ISMP International Medication Safety Self Assessment® for Oncology" . Journal of Oncology Pharmacy Practice . 21 (1): 26–35. doi:10.1177/1078155214556522. ISSN   1078-1552. PMID   25361598. S2CID   36967892.
  8. ↑ McCarthy, Kaitlyn R.; Christakos, Eugenia; Kurzatkowski, Amy; Gernant, Stephanie A. (2021-07-01). "Characterizing perceptions of an abbreviated ISMP Medication Safety Self Assessment for community pharmacies". Journal of the American Pharmacists Association . 61 (4): S105 –S117. doi: 10.1016/j.japh.2021.02.013 . ISSN   1544-3191. PMID   33812781. S2CID   233029198.
  9. ↑ Mancano, Michael A.; Esordi, Morgan V.; Patel, Darshil D.; Milenki, Kristen J. (2019-04-01). "ISMP Adverse Drug Reactions: Longitudinal Thumbnail Fissures Due to Erlotinib Priapism Associated With the Use of ExtenZe Blindness From a Nevirapine-Based HAART Regimen Hyperprolactinemia and Galactorrhea Due to Aripiprazole Trypophobia Associated With Gabapentin Coadministered Linezolid and Methadone Cause Serotonin Syndrome". Hospital Pharmacy. 54 (2): 88–92. doi:10.1177/0018578718824449. ISSN   0018-5787. PMC   6431722 . PMID   30923400.
  10. ↑ Mancano, Michael A. (2018-02-01). "ISMP Adverse Drug Reactions: Influenza Vaccine–Induced Stevens-Johnson Syndrome; Vilazodone-Induced Nightmares; Dabigatran-Induced Pustular Eruptions; Neurotoxic and Cardiotoxic Symptoms After Cannabis Concentrate Exposure; Rosuvastatin-Induced Skin Eruption". Hospital Pharmacy. 53 (1): 15–17. doi:10.1177/0018578717739727. ISSN   0018-5787. PMC   5805017 . PMID   29434381.
  11. ↑ Mancano, Michael A.; Lapin, Jonathan; Paik, Andrew (2019-08-01). "ISMP Adverse Drug Reactions: Pheochromocytoma Crisis Induced by Metoclopramide Baclofen Dependence Following High-Dose Therapy Fatal Cardiotoxicity Following High-Dose Cyclophosphamide Acute Anterograde Amnestic Syndrome Induced by Fentanyl Ivermectin-Induced Toxic Epidermal Necrolysis Pembrolizumab-Induced Type 1 Diabetes". Hospital Pharmacy. 54 (4): 241–245. doi:10.1177/0018578719828860. ISSN   0018-5787. PMC   6628555 . PMID   31320773.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.